99% Savings - Buy Just @1 Rs X
Olmeglare CH 40 Mg/6.25 Mg Tablet is a commercial drug that is prescribed in the form of Tablet. Olmeglare CH 40 Mg/6.25 Mg Tablet also has some secondary and off-label uses. These are listed below.
The correct dosage of Olmeglare CH 40 Mg/6.25 Mg Tablet depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Common side effects of Olmeglare CH 40 Mg/6.25 Mg Tablet include Headache, Nausea or vomiting, Diarrhoea. These side effects of Olmeglare CH 40 Mg/6.25 Mg Tablet are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Olmeglare CH 40 Mg/6.25 Mg Tablet's effect during pregnancy is Severe and Severe while nursing. It is important to know if Olmeglare CH 40 Mg/6.25 Mg Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Olmeglare CH 40 Mg/6.25 Mg Tablet related warnings section.
Olmeglare CH 40 Mg/6.25 Mg Tablet is contraindicated in people with pre-existing medical conditions like Kidney Disease, Liver Disease as it can result in adverse effects.
Drug reaction of Olmeglare CH 40 Mg/6.25 Mg Tablet with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Olmeglare CH 40 Mg/6.25 Mg Tablet is considered not safe while driving, and is not addictive.
Olmeglare CH 40 Mg/6.25 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Olmeglare CH 40 Mg/6.25 Mg Tablet safe for pregnant women?
Olmeglare Ch can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Olmeglare CH 40 Mg/6.25 Mg Tablet safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Olmeglare Ch. It should only be taken after medical advice.
What is the effect of Olmeglare CH 40 Mg/6.25 Mg Tablet on the Kidneys?
There may be some adverse effects on kidney after taking Olmeglare Ch. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Olmeglare CH 40 Mg/6.25 Mg Tablet on the Liver?
Olmeglare Ch may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Olmeglare CH 40 Mg/6.25 Mg Tablet on the Heart?
Olmeglare Ch can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
If you are suffering from any of the following diseases, you should not take Olmeglare CH 40 Mg/6.25 Mg Tablet unless your doctor advises you to do so -
Is this Olmeglare CH 40 Mg/6.25 Mg Tablet habit forming or addictive?
Forming a habit of Olmeglare CH 40 Mg/6.25 Mg Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Olmeglare CH 40 Mg/6.25 Mg Tablet can make you feel drowsy.
Is it safe?
Yes, but take Olmeglare CH 40 Mg/6.25 Mg Tablet only as per medical advice.
Is it able to treat mental disorders?
No, Olmeglare CH 40 Mg/6.25 Mg Tablet cannot treat any kind of mental disorder.
Interaction between Food and Olmeglare CH 40 Mg/6.25 Mg Tablet
There is no information on the effects of taking Olmeglare CH 40 Mg/6.25 Mg Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Olmeglare CH 40 Mg/6.25 Mg Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Olmeglare CH 40 Mg/6.25 Mg Tablet with alcohol will be.
No, Olmeglare Ch is a prescription drug so do not take it without consulting a doctor. It can be harmful to the patient to take this medicine without a doctor's recommendation because it can cause very unpleasant side effects. Hence, the patient should seek doctors advice before taking this medication by himself or herself.
Yes, you may take Olmeglare Ch with metoprolol as it will help in reducing high blood pressure and slow the heart rate. But using this combination may cause some side effects like dizziness, weakness, fainting, fast or irregular heartbeats, or loss of blood glucose control. If you experience any of these side effects then consult it with your doctor immediately.
Yes, Olmeglare Ch can be taken at night but you are advised to take it in the morning to avoid sleep disturbances caused by excessive urination during the night.
Take Olmeglare Ch as advised by your doctor. Do not discontinue the drug suddenly or take it longer than prescribed by your doctor.
Yes, you may feel dizzy after taking [Medicine. It has been reported by the patients who are taking this drug. If you are experiencing the same after taking this drug, you are advised to consult about it with your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173